Millie
your market intelligence analyst
Search Results
171 results
Your search is now limited to «Bristol-Myers Squibb» expert search.
Zacks.com 07/19/2019 16:57
Investors will focus on regular top- and bottom-line numbers along with updates on the Celgene merger, when Bristol-Myers (BMY) reports second-quarter results.
More from Zacks.com:
PharmaTimes 07/19/2019 07:55
Encouraging early data have been seen with the studied combination, as in a Phase Ib investigator sponsored trial from Japan called REGONIVO.
More from PharmaTimes:
PharmiWeb.com 07/19/2019 07:17
WHIPPANY, N.J. & PRINCETON, N.J. & OSAKA, Japan--(BUSINESS WIRE)--Bayer, Bristol-Myers Squibb Company(NYSE: BMY) and Ono Pharmaceutical Co., Ltd. ("Ono") announced today the three companies have entered into a clinical collaboration agreement to evaluate the combination of Bayer’s kinase inhibitor Stivarga® (regorafenib) and Bristol-Myers Squibb’s / Ono’s anti-PD-1 immune checkpoint inhibitor, Opdivo® (nivolumab) in patients with micro-satellite stable metastatic colorecta...
More from PharmiWeb.com:
Seeking Alpha 07/18/2019 10:21
Once the FTC accepts the consent order and the other customary closing conditions are satisfied, Bristol-Myers Squibb intends to close the Celgene transaction at the earliest possible date, which it currently expects to be at the end of 2019 or the beginning of 2020.
More from Seeking Alpha:
Big News Network (UAE) 07/18/2019 08:40
Bristol-Myers has an Earnings ESP of +0.28% at the moment, suggesting that analysts have grown bullish on its near-term earnings potential.
More from Big News Network (UAE):
PR Newswire 07/18/2019 06:32
Bayer, Bristol-Myers Squibb and Ono Pharmaceutical enter into a clinical collaboration agreement to investigate Stivarga® (regorafenib) and Opdivo® (nivolumab) as combination therapy in patients with metastatic colorectal cancer.
More from PR Newswire:
Bayer 07/18/2019 06:30
Bayer, Bristol-Myers Squibb and Ono Pharmaceutical enter into a clinical collaboration agreement to investigate Stivarga® (regorafenib) and Opdivo® (nivolumab) as combination therapy in patients with colorectal cancer.
World Pharma News 07/18/2019 04:00
Bayer, Bristol-Myers Squibb and Ono Pharmaceutical enter into a clinical collaboration agreement.
More from World Pharma News:
National Law Review 07/12/2019 14:31
Southern District of California case, McCurley v. Royal Seas Cruises, Telephone Consumer Protection Act TCPA defendant learned best course is to raise the defense at pleading stage to avoid waiver, challenge personal jurisdiction of claims of absent class members at pleadings stage.
More from National Law Review:
Motley Fool 07/08/2019 10:26
In fact, Bristol's shares broke through their five-year low last April, underscoring just how poorly this big pharma stock has performed so far this year.
More from Motley Fool:
FierceMedicalDevices 07/02/2019 11:26
A team of researchers in Germany has now found a possible solution in Bristol-Myers Squibb’s leukemia drug Sprycel.
More from FierceMedicalDevices:
Business Wire 07/01/2019 05:17
UPSA is focused on delivering important consumer medicines in France, across Europe and additional countries that are outside of the Bristol-Myers Squibb core focus.
More from Business Wire:
ENDPOINTS 06/25/2019 14:02
A number of top analysts went right after AbbVie’s rationale for the Allergan deal today, just as Bristol-Myers Squibb stirred immediate debate over the worth and wisdom of acquiring Celgene.
More from ENDPOINTS:

Therapeutic Areas

Clinical Trials and Phases

Business Issues

Companies - Public

Companies - Venture Funded

Financial Results

Global Markets

Global Risk Factors

Government Agencies

Job Titles

Legal and Regulatory

Cell Receptors

Cells

Diagnostics and Therapeutics

Diseases

Drugs - Brand Names

Drugs - Generic

Enzymes

Genes

Health Care

Health and Wellness

Human Anatomy

Mechanisms of Action

Medical Devices

Proteins

Sources

Strategic Scenarios

Trends

Hints:

On this page, you see the results of the search you have run.  You may also view the following:

  •  Click on this drop-down menu on the right hand side of the page, to choose between the machine learning-produced Insights Reports, or the listing of concepts extracted from the results, in chart or list format. 


  •  View the number of search results returned for the search in each of your collections, and click on any of those numbers to view the entire listing of results from the chosen collection.

  •  Use the search adjustment drop-downs to change the scope, sorting, and presentation of your results.

  •  Show or hide the record’s caption (content description).

  •  Show actions that can be made with the search result record.

  •  Click on the Save button after running your search, to save it so that its results will be updated each time relevant new content is added to the designated collection. You may choose to be notified via search alerts.

Click here for more info on Search Results

Click here for more info on Machine Learning applications